Home > Interventions for Adult Offenders With...

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Interventions for Adult Offenders With Serious Mental Illness

Interventions for Adult Offenders With Serious Mental Illness

Comparative Effectiveness Reviews, No. 121

Investigators: Joann Fontanarosa, PhD, Stacey Uhl, MSS, Olu Oyesanmi, MD, MPH, and Karen M Schoelles, MD, SM.

ECRI Institute Evidence-based Practice Center
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug.
Report No.: 13-EHC107-EF
Copyright and Permissions

Structured Abstract

Objective:

To comprehensively review the evidence for treatments for offenders with serious mental illness (i.e., schizophrenia, schizoaffective disorder, bipolar disorder, or major depression) in jail, prison, or forensic hospital, or transitioning from any of these settings to the community (e.g., home, halfway house).

Data sources:

We searched 12 internal and external databases including MEDLINE®, PreMEDLINE®, and Embase® for the time period January 1, 1990, through August 20, 2012.

Review methods:

We refined the topic, Key Questions, and protocol with experts in the field and determined the study inclusion criteria and risk-of-bias items a priori. Abstract and full-text review and the risk-of-bias assessment were done in duplicate. A second reviewer verified data extraction. Extracted study information included study design, patient enrollment and baseline characteristics, risk-of-bias items, and outcome data. Because of the nature of the available evidence, we chose to perform a qualitative synthesis rather than meta-analysis. We graded the strength of evidence for each treatment comparison and outcome based on the size, risk of bias, and results of the evidence base. We discussed applicability by focusing on the populations, interventions, and settings of the studies.

Results:

We included 19 publications describing 16 comparative trials. The studies were conducted in the United States, Canada, United Kingdom, New Zealand, and Australia. The risk of bias for all reported outcomes was medium for 15 trials and low for 1 trial.

For incarceration-based interventions, evidence of low strength favored antipsychotics other than clozapine over treatment with clozapine for improving psychiatric symptoms. For all other incarceration-based interventions assessed—other pharmacologic therapies, cognitive therapy, and modified therapeutic community—evidence was insufficient to draw any conclusions.

For individuals transitioning from the incarceration setting to the community, evidence of low strength supported discharge planning with benefit-application assistance and integrated dual disorder treatment compared with standard of care for increasing mental health service use and/or reducing psychiatric hospitalizations. Evidence was insufficient for comparing interventions administered by a forensic specialist with interventions administered by mental health professionals and for comparing interpersonal therapy with psychoeducation for offenders transitioning from incarceration to the community.

More comparative trials are needed to increase our confidence in the findings for which the strength of evidence is low and to address the questions for which the evidence was insufficient.

Conclusions:

We identified some promising treatments for individuals with serious mental illness during incarceration or during transition from incarceration to community settings. Treatment with antipsychotics other than clozapine appears to improve psychiatric symptoms more than clozapine in an incarceration setting. Two interventions, discharge planning with Medicaid-application assistance and integrated dual disorder treatment programs, appear to be effective interventions for seriously mentally ill offenders transitioning back to the community. The applicability of our findings may be limited to the populations and settings in the included studies.

Contents

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1, Contract No. 290-2007-10063-I, Prepared by: ECRI Institute Evidence-based Practice Center, Plymouth Meeting, PA

Suggested citation:

Fontanarosa J, Uhl S, Oyesanmi O, Schoelles KM. Interventions for Adult Offenders With Serious Mental Illness. Comparative Effectiveness Review No. 121. (Prepared by the ECRI Institute Evidence-based Practice Center under Contract No. 290-2007-10063-I.) AHRQ Publication No. 13-EHC107-EF. Rockville, MD: Agency for Healthcare Research and Quality; August 2013. www.effectivehealthcare.ahrq.gov/reports/final.cfm.

This report is based on research conducted by the ECRI Institute Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2007-10063-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients.

This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

None of the investigators have any affiliations or financial involvement that conflicts with the material presented in this report.

1

540 Gaither Road, Rockville, MD 20850; www​.ahrq.gov

Download

AHRQ (US Agency for Healthcare Research and Quality)

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...